{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:33:59Z","timestamp":1787592839837,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejso.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T19:21:08Z","timestamp":1666898468000},"page":"611-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2367-7714","authenticated-orcid":false,"given":"Job P.","family":"van Kooten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornedine J.","family":"de Gooijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9699-4860","authenticated-orcid":false,"given":"Jan H.","family":"von der Th\u00fcsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra R.M.","family":"Brandt-Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend G.J.","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J.","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8690-3811","authenticated-orcid":false,"given":"Kim","family":"Monkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus A.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim G.J.V.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva V.E.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.10.003_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","article-title":"Lymph node metastases in diffuse malignant peritoneal mesothelioma","volume":"17","author":"Baratti","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.21037\/atm.2017.03.96","article-title":"Malignant peritoneal mesothelioma: a review","volume":"5","author":"Kim","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejso.2022.10.003_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant mesothelioma and its non-asbestos causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejso.2022.10.003_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejso.2022.10.003_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.21037\/tlcr-19-620","article-title":"Update on the pathologic diagnosis of malignant mesothelioma","volume":"9","author":"Schulte","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ejso.2022.10.003_bib6","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.5858\/2006-130-1654-PSOHPI","article-title":"Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma","volume":"130","author":"Cerruto","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejso.2022.10.003_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","article-title":"Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1245\/s10434-018-07153-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum: a retrospective study from the renape observational registry","volume":"26","author":"Vogin","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib9","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2019-0024","article-title":"Multicystic peritoneal mesothelioma: a systematic review of the literature","volume":"4","author":"Noiret","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2022.10.003_bib10","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1245\/s10434-018-6337-5","article-title":"Current management and future opportunities for peritoneal metastases: peritoneal mesothelioma","volume":"25","author":"Alexander","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","article-title":"Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib12","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib13","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"Janne","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejso.2022.10.003_bib15","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","article-title":"Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial","volume":"26","author":"Simon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib16","volume":"9","author":"de Boer","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejso.2022.10.003_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1586\/14737140.2014.919859","article-title":"Immune therapies for malignant mesothelioma","volume":"14","author":"Antoniu","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejso.2022.10.003_bib18","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1245\/s10434-019-07803-z","article-title":"Malignant peritoneal mesothelioma: patterns of care and survival in The Netherlands: a population-based study","volume":"26","author":"de Boer","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2020.09.004","article-title":"Increased disease-free and relative survival in advanced ovarian cancer after centralized primary treatment","volume":"159","author":"Palmqvist","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/SLA.0000000000004326","article-title":"Centralization and oncologic training reduce postoperative morbidity and failure-to-rescue rates after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: study on a 10-year national French practice","volume":"272","author":"Noiret","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.10.003_bib21","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/bjs.10931","article-title":"Overall survival before and after centralization of gastric cancer surgery in The Netherlands","volume":"105","author":"van Putten","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.10.003_bib22","series-title":"Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study","author":"van Kooten","year":"2022"},{"key":"10.1016\/j.ejso.2022.10.003_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","article-title":"Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ejso.2006.03.012","article-title":"Comprehensive management of diffuse malignant peritoneal mesothelioma","volume":"32","author":"Sugarbaker","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib25","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1245\/s10434-017-6033-x","article-title":"Conversion to complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma after bidirectional chemotherapy","volume":"24","author":"Le Roy","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib26","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1245\/s10434-021-10983-2","article-title":"Non-resectable malignant peritoneal mesothelioma treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) plus systemic chemotherapy could lead to secondary complete cytoreductive surgery: a cohort study","volume":"29","author":"Kepenekian","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib27","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1245\/s10434-021-10048-4","article-title":"Cytoreductive surgery plus HIPEC with and without NIPEC for malignant peritoneal mesothelioma: a propensity-matched analysis","volume":"28","author":"Sugarbaker","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","article-title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study","volume":"18","author":"Gatta","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib29","series-title":"City: Dutch cancer registry","article-title":"Zwan Kankerzorg in beeld: zeldzame kanker","author":"Blauwgeers","year":"2018"},{"key":"10.1016\/j.ejso.2022.10.003_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jso.21787","article-title":"Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research","volume":"103","author":"Baratti","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The role of ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Kusamura","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/02656736.2018.1434902","article-title":"Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival","volume":"34","author":"Gilani","year":"2018","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2022.10.003_bib33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/COC.0b013e3182a0e867","article-title":"Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma","volume":"38","author":"Pillai","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib34","first-page":"2","article-title":"Ki67 (MIB-1) as a prognostic marker for clinical decision making before extended pleurectomy decortication in malignant pleural mesothelioma","author":"Belderbos","year":"2021","journal-title":"JTO Clin Res REp"},{"key":"10.1016\/j.ejso.2022.10.003_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1200\/JOP.2016.011908","article-title":"Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy","volume":"12","author":"Sugarbaker","year":"2016","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.ejso.2022.10.003_bib36","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A\u00a0novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database","volume":"117","author":"Yan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.10.003_bib37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2006.05.009","article-title":"Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma","volume":"32","author":"Yan","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejso.2022.10.003_bib39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jso.21601","article-title":"Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study","volume":"102","author":"Esquivel","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.10.003_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:45:26Z","timestamp":1760060726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322006953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0748798322006953"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.10.003","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}